The landmark for removal of sialoliths using sialendoscopy alone in parotid gland sialolithiasis

One‐year outcomes of sialendoscopic‐assisted salivary duct surgery for sialadenitis without sialolithiasis

“…In this study, we present a prospective analysis of etiology‐specific responses to SASDS in patients with COSWS using the COSS questionnaire. Previous studies have shown that symptomatic response to SASDS varies in an etiology‐dependent manner, most likely reflecting different drivers of inflammation and obstruction in chronic sialadenitis . Although evidence for efficacy of SASDS in the treatment of sialolithiasis is robust, the limited power and generalizability of SASDS outcomes for COSWS can be attributed to predominantly retrospective design of most published studies, small sample sizes given the rare incidence of COSWS, short duration of postoperative follow‐up, and heterogeneous cohorts with an emphasis on sialolith‐based disorders.…”

“…The efficacy of sialendoscopy‐assisted salivary duct surgery (SASDS) in treating chronic obstructive sialadenitis due to sialolithiasis has been well documented . The role of SASDS in the treatment of COSWS due to stenosis, inflammation from autoimmune disease, and radioactive iodine‐induced sialadenitis (RAI‐IS) has been previously explored, although primarily through retrospective analyses .…”

“…[1][2][3] The efficacy of sialendoscopy-assisted salivary duct surgery (SASDS) in treating chronic obstructive sialadenitis due to sialolithiasis has been well documented. [4][5][6][7][8][9] The role of SASDS in the treatment of COSWS due to stenosis, inflammation from autoimmune disease, and radioactive iodine-induced sialadenitis (RAI-IS) has been previously explored, although primarily through retrospective analyses. [10][11][12][13][14][15][16] Recently, our group used the 20-item Chronic Obstructive Sialadenitis Symptoms (COSS) Questionnaire to quantify short-term (3-month) symptom improvements in patients with COSWS, showing at least partial symptom alleviation in a majority of patients with stenoses and RAI-IS.…”

One‐Year symptom outcomes after sialolithiasis treatment with sialendoscopy‐assisted salivary duct surgery

“…Various symptom and outcome instruments and approaches have been employed to assess the efficacy of SASDS . The recently developed Chronic Obstructive Sialadenitis Symptoms (COSS) questionnaire by our group has been used to measure the impact of treatments on sialadenitis‐specific symptoms in a retrospective study and in a series of short‐term (3‐month follow‐up) prospective studies .…”

“…[1][2][3][4] Various symptom and outcome instruments and approaches have been employed to assess the efficacy of SASDS. [5][6][7][8][9][10][11][12][13][14][15][16] The recently developed Chronic Obstructive Sialadenitis Symptoms (COSS) questionnaire by our group has been used to measure the impact of treatments on sialadenitis-specific symptoms in a retrospective study and in a series of short-term (3-month follow-up) prospective studies. [17][18][19][20][21] Based on the current body of relevant literature, the long-term durability of symptom reduction following SASDS and risk factors for treatment failure remain unclear.…”